Gliclazide Prevents 5-FU-Induced Oral Mucositis by Reducing Oxidative Stress, Inflammation, and P-Selectin Adhesion Molecules
Open Access
- 26 March 2019
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 10, 327
Abstract
Oral mucositis (OM) is one of the main side effects of the head and neck cancer treatment, particularly radiotherapy and/or chemotherapy. OM is characterized by ulcers, erythema, dysphagia, xerostomia, and increased susceptibility to opportunistic infections. In the perspective of finding pharmacological therapies to prevent inflammation and ulceration of OM, the investigation of the pleiotropic effect of commercial drugs is needed, among them gliclazide, an antidiabetic drug. This study aimed to evaluate the effect of gliclazide in an experimental OM model induced by 5-fluorouracil. Male hamsters were pre-treated with oral gliclazide (1, 5, or 10 mg/kg) for 10 days. Cheek pouch samples were subjected to histopathological and immunohistochemical analysis (COX2, iNOS, MMP-2, NFκB P65, GPx) and imunofluorescence (P-selectin). IL-1β and TNF-α levels, Myeloperoxidase activity (MPO) and malondialdehyde (MDA) levels were investigated by ultraviolet-visible spectroscopy analysis. NFκB NLS P50 protein levels were analyzed by western blotting. The group treated with gliclazide at a dose of 10 mg/kg showed presence of erythema, no evidence of erosion, and absence of mucosal ulceration with a score of 1 (1–2) (p < 0.01). Histopathological data for the group treated with gliclazide 10 mg/kg showed re-epithelialization, discrete mononuclear inflammatory infiltrate and absence of hemorrhage, edema, ulcers and abscesses with a score of 1 (1–1) (p < 0.01). Treatment with gliclazide 10 mg/kg reduced MPO activity (p < 0.001), MDA levels (p < 0.001) and NFκB NLS P50 (p < 0.05) protein levels, resulting in low immunostaining to Cox-2, iNOS (p < 0.05), NFκB P65 (p < 0.05), and negative immunoreaction to MMP-2 (p < 0.001). However, it appeared that for Gpx1, the staining was restored in the GLI 10-FUT group compared with 5FUT/saline (p < 0.05). Immunofluorescence revealed decreased levels of P-selectin (p < 0.001) after treatment with gliclazide 10 mg/kg (p < 0.05). In summary, gliclazide accelerated mucosal recovery and reduced oxidative stress and inflammation in the 5-FU-induced OM in hamsters.Keywords
Funding Information
- Universidade Federal do Rio Grande do Norte
This publication has 59 references indexed in Scilit:
- Oxidative Stress and Antioxidant DefenseWorld Allergy Organization Journal, 2012
- Gliclazide may have an antiapoptotic effect related to its antioxidant properties in human normal and cancer cellsMolecular Biology Reports, 2011
- Temporal and spatial correlation of platelet-activating factor-induced increases in endothelial [Ca2+]i, nitric oxide, and gap formation in intact venulesAmerican Journal of Physiology-Heart and Circulatory Physiology, 2011
- Estimation of Lipid Peroxidation Induced by Hydrogen Peroxide in Cultured Human LymphocytesDose-Response, 2011
- Endothelial nitric oxide synthase transgenic models of endothelial dysfunctionPflügers Archiv - European Journal of Physiology, 2010
- Review: Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based managementTherapeutic Advances in Medical Oncology, 2009
- The Nuclear Factor NF- B Pathway in InflammationCold Spring Harbor Perspectives in Biology, 2009
- Genetic Evidence Supporting a Critical Role of Endothelial Caveolin-1 during the Progression of AtherosclerosisCell Metabolism, 2009
- Internalization of eNOS via caveolae regulates PAF-induced inflammatory hyperpermeability to macromoleculesAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Endothelial nitric oxide synthase regulates microvascular hyperpermeability in vivoThe Journal of Physiology, 2006